Dr Lal PathLabs Q1 Results: Profit Rises 29%, Beats Estimates

Dr Lal PathLabs Ltd.’s first quarter profit surged, beating analysts' estimates.

The diagnostic and healthcare testing services provider’s net profit rose 29% year-on-year to Rs 108 crore in the quarter-ended June, according to its exchange filing. That compares with the Rs 99-crore consensus estimate of analysts tracked by Bloomberg.

Dr Lal PathLabs Q1 FY25 Highlights (YoY)

Revenue up 11.3% to Rs 602 crore versus Rs 541 crore (Bloomberg Estimate: Rs 605 crore).
Ebitda up 16.4% to Rs 170 crore versus Rs 146 crore (Bloomberg Estimate: Rs 163 crore).
Margin at 28.2% versus 27% (Bloomberg Estimate: 27%).
Net profit up 28.6% to Rs 108 crore versus Rs 84 crore (Bloomberg Estimate: Rs 99 crore).

Shares of Dr Lal PathLabs gained 3.7% after the results were announced, as compared with a 1.27% rise in the benchmark Nifty.

Also Read: Dr Lal Pathlabs To Open 20 Hubs In Tier 3 Cities | NDTV Profit

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.

GET REGULAR UPDATES

Add us to your Preferences

Set as your preferred source on Google